Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam
(include interim analysis): File the New Drug Application of MVC EV71 Vaccine (Envacgen) to Drug Administration of Vietnam. (2)Once disapproved by competent authority or each of clinical trials (include interim analysis) results less than statistically significant sense, the risks & the associated measures the Company may occur: N/A. (3)After obtaining official approval or the results of statistically significant sense, the future strategy: N/A. (4)Accumulated investment expenditure incurred: Based on business strategy considerations, it will not be disclosed for the time being.